Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Terazosin And Metabolic Engagement in Alzheimer's Disease

The TAME-AD trial will be a randomized, double-blind, placebo-controlled Phase IIa clinical trial to evaluate the metabolic target engagement of terazosin for the treatment of Alzheimer's disease.

Participants needed: 100
Trial details
Phase: Phase 2Age: 50-80Biological sex: AllType: InterventionalSponsor: Qiang ZhangUpdated: Sep 1, 2026Locations: 1
Eligibility criteria

Male or female, aged 50-80 years (inclusive) at the time of consent. [+4]

Unwilling or unable to provide written informed consent or - where decisional ca... [+29]

Status: Not yet recruiting

Terazosin for Dementia With Lewy Bodies

The TZ-DLB trial will be a 3:2 (active:placebo) randomized, double-blind, placebo-controlled Pilot trial to evaluate the tolerability of terazosin for the treatment of dementia with Lewy bodies.

Participants needed: 40
Trial details
Phase: Phase 1, Phase 2Age: 0-90Biological sex: AllType: InterventionalSponsor: Qiang ZhangUpdated: Mar 12, 2026Locations: 1
Eligibility criteria

Men or women with the diagnosis of dementia with Lewy Bodies per 2017 DLB Consor... [+1]

Subjects unwilling or unable to give informed consent [+10]